Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/14/15 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
68 | |
| 08/13/15 | Current report filing |
|
8 | ||
| 08/10/15 | Prospectus filed pursuant to Rule 424(b)(3) |
|
20 | ||
| 08/07/15 | Notice of Effectiveness |
|
1 | ||
| 08/04/15 | Initial statement of beneficial ownership of securities |
|
4 | ||
| 07/20/15 | Current report filing |
|
3 | ||
| 07/20/15 | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
30 | ||
| 07/09/15 | Current report filing |
|
3 | ||
| 06/12/15 | Prospectus filed pursuant to Rule 424(b)(3) |
|
25 | ||
| 06/11/15 | Notice of Effectiveness |
|
1 |